Evidence map›Paper›PMID 41356726›Full record

ArticleCase reports in cardiology2025

Low-Dose Catheter-Directed Thrombolysis for Massive Pulmonary Embolism: A Case Report Highlighting Dosing Considerations in Asian Patients.

Zhongjian Tang, Yang Song, Min Zhang, Mengyan Li, Jingjing Shang, Aiya Shu, Kunkun Wang, Yun Lucy Lu

Abstract readCase Reports
In one paragraph

Article in Case reports in cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhongjian TangDepartment of Intensive Care Unit, Fuling Center Hospital of Chongqing, Chongqing, China.
Yang SongDepartment of Pharmacy, St. Joseph Medical Center, Tacoma, Washington, USA.
Min ZhangDepartment of Pharmacy Services, Boston Medical Center, Boston, Massachusetts, USA.
Mengyan LiDepartment of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jingjing ShangDepartment of Intensive Care Unit, Fuling Center Hospital of Chongqing, Chongqing, China.
Aiya ShuDepartment of Intensive Care Unit, Fuling Center Hospital of Chongqing, Chongqing, China.
Kunkun WangFMH Pharmacy, Fairbanks Memorial Hospital, Fairbanks, Alaska, USA.ORCID https://orcid.org/0000-0002-5916-0311
Yun Lucy LuDepartment of Pharmacy, Hennepin Healthcare System, Minneapolis, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical management of massive pulmonary embolism is challenging when active hemorrhage, a contraindication to thrombolytics, is concurrently present. We describe a successful attempt in using low-dose catheter-directed thrombolysis (CDT) in a high-risk patient with absolute contraindications to systemic thrombolysis. A 69-year-old Asian female with cardiac arrest was brought to a resource-limited rural hospital. The patient underwent 50 min of cardiopulmonary resuscitation (CPR) before regaining the pulse but remained in cardiogenic shock. Computerized tomography (CT) of the chest found massive PE. The patient was found with multiple fractures and subarachnoid hemorrhage. Catheter-directed embolectomy was performed without clinical improvement. A low-dose CDT with alteplase was attempted by giving 5 mg over 2 h with a repeated session 24 h later for a total of 10 mg. The patient started improving, was extubated on Day 9, and transferred out of the ICU on Day 15. Low-dose CDT in massive PE could be lifesaving despite the presence of absolute alteplase contraindications. Patients with contraindications, a high risk of bleeding, or of Asian race may benefit more from the low-dose alteplase regimen.

Indexed as

embolismracethrombolysisthrombosis

Identifiers

PMID41356726
PMCPMC12681412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.